![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Shechter M.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.3, Iss.4, 2003-01, pp. : 231-239
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Economic Benefits of Amlodipine Treatment in Patients with Coronary Artery Disease
By Casciano R.
PharmacoEconomics, Vol. 20, Iss. 8, 2002-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Longobardi Giancarlo Ferrara Nicola Leosco Dario Abete Pasquale Furgi Giuseppe Cacciatore Francesco Corbi Graziamaria Pescatore Raffaella Rengo Franco
Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of inflammatory markers in coronary artery disease
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prognostic Role of miRNAs in Coronary Artery Disease
Current Topics in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-07 ,pp. :